A Study of Degarelix Before Prostatectomy in Patients with Intermediate- to High-Risk Prostate Cancer
[Protocol 11-182] |
Rathkopf, Dana |
|
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study
[Protocol 12-250] |
Reidy-Lagunes, Diane |
- Lung Cancer
- Upper Gastrointestinal
|
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of GSK2118436 in Patients with Advanced Non-Small Cell Lung Cancer and BRAF Mutations
[Protocol 11-023] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I/II Study of the ALK Inhibitor CH5424802 in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
[Protocol 12-113] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I/II Trial of AUY-922 in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
[Protocol 11-015] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of LDK378 in Adults with Non-Small Cell Lung Cancers Containing an ALK Gene Fusion
[Protocol 11-055] |
Riely, Gregory |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] |
Riely, Gregory |
- Lung Cancer, Non-Small Cell
|
Phase I Study of PF-02341066 in People with Advanced Cancer
[Protocol 07-157] |
Riely, Gregory |
|
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003] |
Rimner, Andreas |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] |
Rimner, Andreas |
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
|
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Cancer
[Protocol 11-037] |
Rizk, Nabil |
|
A Prospective Study to Determine if Variations in Tissue Oxygenation Are Associated with Leak Rates after Esophagectomy
[Protocol 11-192] |
Rizk, Nabil |
|
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase III Study of BMS-936558 versus Docetaxel in Patients with Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
[Protocol 12-252] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of BMS-936558 with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189] |
Rizvi, Naiyer |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase III Study of BMS-936558 versus Docetaxel in Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-203] |
Rizvi, Naiyer |
|
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer |
- Lung Cancer, Non-Small Cell
- Melanoma
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Solid Tumors
|
A Phase Ib Study of Combination Therapy with MSC1936369B and SAR245409 in Patients with Locally Advanced or Metastatic Solid Tumors
[Protocol 12-107] |
Rizvi, Naiyer |
|
